Kidamycin
Appearance
![]() | |
Names | |
---|---|
Other names
Rubiflavin B
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
| |
| |
Properties | |
C39H48N2O9 | |
Molar mass | 688.818 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Kidamycin is an anthracycline antibiotic with anticancer activity.[1] It was first synthesized from a strain of streptomyces bacteria isolated from a soil sample.[2] In clinical trials, Kindamycin showed high effect against gram positive bacteria as well as multiple cancer models including Ehrlich ascites carcinoma, Sarcoma 180, NF-sarcoma, and Yoshida sarcoma.[3]
References
[edit]- ^ Furukawa, M.; Hayakawa, I.; Ohta, G.; Iitaka, Y. (1 January 1971). "Structure and chemistry of kidamycin". Tetrahedron. 31 (23): 2989–2995. doi:10.1016/0040-4020(75)80324-3.
- ^ Kanda, N. (Sep 1971). "A new antitumor antibiotic, kidamycin. I. Isolation, purification and properties of kidamycin". The Journal of Antibiotics. 24 (9): 599–606. doi:10.7164/antibiotics.24.599. PMID 5132247.
- ^ Kanda, Nobuo; Kono, Morihiro; Asano, Kazuo (1972). "A New Antitumor Antibiotic, Kidamycin". The Journal of Antibiotics. 25 (10): 553–556. doi:10.7164/antibiotics.25.553. ISSN 0021-8820. PMID 4648309.